Isabel Cristina Durango

1. Durango I. Approach to the Patient with Prolonged PT and/or aPTT. XIII Symposium of Internal Medicine Residents, Universidad Pontificia Bolivariana. Approaches in Internal Medicine. 2007;7-18. 2. Durango I. Malaria. XII Symposium of Internal Medicine Residents, Universidad Pontificia Bolivariana. Infectious Diseases. 2006;21-29. 3. Ortiz M, Restrepo J, Zuleta J, Durango I, Hoyos S, Guzmán C, Mena A, Correa G. Serum Phosphorus Levels as a Prognostic Marker in the Immediate Post–Liver Transplant Period. Revista Colombiana de Gastroenterología. 2009;24(1):26-32. 4. Builes C, Durango I, Velásquez C. Systemic Lupus Erythematosus with Negative Antinuclear Antibodies and Hemolytic Anemia. Acta Médica Colombiana. 2010;35(4):October–December. 5. Quintero JA, Sánchez JO, Llinás NE, Durango IC, Guarnizo C, Rubiano JA, Rivas G, Grosso F, Cuello J, Arango N. Oncological Treatment of Cutaneous Angiosarcoma: Literature Review. Revista Colombiana de Cancerología. 2012;16(1). 6. Rivas G, Arango N, Rubiano J, Vargas Y, Sánchez O, Garavito G, Cuello J, Quintero J, Grosso F, Durango I. Adrenocortical Carcinoma: Literature Review. Revista Colombiana de Cancerología. 2012;16(2). 7. Sánchez JO, Díaz SE, Guzmán LH, Quiroga A, Durango IC, Arango N, Ríos DC. Clinical Experience with Neoadjuvant Chemotherapy Using Doxorubicin and Cyclophosphamide in Patients with Locally Advanced Breast Cancer at the Instituto Nacional de Cancerología, Bogotá, Colombia. Revista Colombiana de Cancerología. Accepted for publication. 8. Overall Survival Prediction in Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223. International Brazilian Journal of Urology. 2020;46:599-611. 9. Genotyping of Melanoma in Colombia. Revista Colombiana de Hematología y Oncología. 2013.